Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-22

Study Completion Date

2019-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France

NCT01531478

Cancer Sequels Complications

COMPLETED

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

NCT04412135

Hematologic Cancer

UNKNOWN

Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up

NCT04711733

Solid Tumor or Lymphoma

COMPLETED

Awareness About Breast Cancer Screening

NCT03777397

Breast Cancer

COMPLETED

Cancer and Sexual Health : Early Information and Sexual Satisfaction of Couples in Oncology

NCT02541162

Cancer

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Haemopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

siblings

Brother or sister of a child has malignant haemopathy and follow-up in the pediatric hematology department

Group Type OTHER

semi-directive interview

Intervention Type OTHER

semi-structured interview conducted by a clinical psychologist

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

semi-directive interview

semi-structured interview conducted by a clinical psychologist

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children from 6 to 12 years old
* Brother or sister of a child:

O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included

* whose parents are able to understand and sign voluntarily informed consent
* Affiliated to a social security scheme
* Ability to understand and answer questions alone during the semi-structured interview

Exclusion Criteria

* Child under 6 years or over 12 years
* Subject with a pathology that may interfere with the course of the study, according to the investigator's assessment
* Absence of the informed consent of one of the parents and / or the legal representative
* Refusal of participation of the subject

Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes